Cell Genesys (CEGE)

CEGE is defunct.

CEGE Related Articles more »

Developments for Parkinson's Disease Ignite Investor Enthusiasm

Michael Becker • Mon, Nov 16, 2009 • 6 Comments
Transformative Times for BioSante Pharmaceuticals

M. E. Garza • Wed, Oct 21, 2009 • 4 Comments
La Jolla Is Too Much of a Gamble Right Now

VFC's Stock House • Wed, Sep 2, 2009 • Comment!
Dealmaking Sweeps the Biotech Sector

The Burrill Report • Sun, Jul 5, 2009 • Comment!
Cell Genesys: BioSante Sees Something Other than Cash

EP Vantage • Wed, Jul 1, 2009 • Comment!
Closing Update for Tuesday June 30

Midnight Trader • Tue, Jun 30, 2009 • Comment!
4 Small Cap Stock Briefs

VFC's Stock House • Wed, Jun 24, 2009 • 3 Comments
Five Biopharma Companies Drop on Negative Drug News

Mike Huckman • Thu, Aug 28, 2008 • 1 Comment
Six Significant Gene Therapy Stocks

Stockerblog • Tue, May 13, 2008 • 2 Comments
Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals

Michael Shulman • Fri, Apr 11, 2008 • 6 Comments

CEGE Latest Transcript more »

Cell Genesys, Inc. Q3 2008 Earnings Call Transcript

Wed, Nov 19, 2008
Popular searches: trials, debt, gvax, reduction, say, sharon, cancer, cege, cell, conference.

Earlier CEGE transcripts

CEGE Cramer more »

Currently, there are no Cramer articles on CEGE.

CEGE Instablog posts more »

Speculative BioTechs: Finding the Next 10-Bagger

Thu, May 7, 2009 • Joe Kunkle • 9 Comments

Company Description

We are a biotechnology company that was focused on the development and commercialization of novel biological therapies for patients with cancer. We were developing cell-based cancer immunotherapies and oncolytic virus therapies to treat different types of cancer. Our clinical stage cancer... More

Country: United States